Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress

Read expert advice about the importance of managing adjuvant abemaciclib adverse events in early breast cancer, from Clinical Care Options (CCO)

Julia LaBarbera, MSN, RN, AGACNP-BC Released: January 31, 2023

Dr Eric Jonasch discusses advances in the care of patients with renal cell carcinoma in this on-demand webcast from Clinical Care Options (CCO)

Naomi B. Haas, MD
Program Director Eric Jonasch, MD
Program Director Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: January 26, 2023 Expired: January 25, 2024

In slides from Clinical Care Options (CCO), experts provide perspectives on updates in biomarker testing and targeted therapy across GI cancers

John L. Marshall, MD
Program Director Christopher H. Lieu, MD Manish A. Shah, MD Released: January 19, 2023

Downloadable slides on multidisciplinary approaches to managing high-risk, HR-positive/HER2-negative early breast cancer, from Clinical Care Options, (CCO)

Erika P. Hamilton, MD
Program Director Joyce O'Shaughnessy, MD
Program Director Released: January 4, 2023